Genetic testing and sweat testing are common ways doctors check for cystic fibrosis. In the United States, testing for this condition is also part of newborn screening. Early diagnosis and ...

My dad tells me that my Uncle Andy was the greatest of kids. He was always smiling, had the vocabulary and sharpness of a literary maestro, and loved exploring. He also never complained a day in his ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

A novel once-daily drug showed a comparable efficacy and safety profile as the standard-of-care drug in patients with cystic ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

No single score captures the burden of treatment in people with cystic fibrosis (pwCF), according to systematic review study findings published in the Journal of Cystic Fibrosis.

The startups are the fourth and fifth drugmakers to file for initial stock sales since late December — the most IPO activity ...

Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...

The Yourgene Cystic Fibrosis Base assay is a Class C in vitro ... relevant diagnostic scenarios in mind such as carrier ...

Discover how poor sleep quality significantly increases malnutrition risk in adolescents with cystic fibrosis. Learn why ...

TC Biopharm (Holdings) plc intends to begin proof-of-concept preclinical studies for its lead therapeutic TCB-008, to treat H5N1, or bird flu. TCB-008 is an allogeneic, unmodified cell therapy ...